Odyssey Health (ODYY) Non-Current Assets (2016 - 2025)
Odyssey Health's (ODYY) quarterly Non-Current Assets came in at $97149.0 in Q2 2025, down 99.28% year-on-year from $13.4 million in Q2 2024, and down 38.71% quarter-over-quarter from $158505.0 in Q1 2025.
Odyssey Health (ODYY) Non-Current Assets (2016 - 2025) Analysis & Trends
Odyssey Health's Non-Current Assets history runs 10 years deep, the most recent figure standing at $97149.0 for Q2 2025.
- On a quarterly basis, Non-Current Assets fell 99.28% year-over-year to $97149.0 in Q2 2025; TTM through Jan 2026 was $97149.0, a 99.32% decrease from a year earlier, with the FY2024 full-year figure at $529203.0, up 960.42% from the prior year.
- Non-Current Assets slipped to $97149.0 in Q2 2025 per ODYY's latest filing, from $158505.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $13.8 million in Q1 2024 and bottomed at $276.0 in Q4 2021.
- The 5-year median for Non-Current Assets is $49375.5 (2023), against an average of $1.6 million.
- Across the five-year window, Non-Current Assets jumped 27597.13% in 2024 and plunged 99.28% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $276.0 in 2021, then jumped by 18213.04% to $50544.0 in 2022, then slipped by 3.13% to $48961.0 in 2023, then surged by 223.74% to $158505.0 in 2024, then tumbled by 38.71% to $97149.0 in 2025.
- Per Business Quant, the three latest ODYY Non-Current Assets figures stand at $97149.0 (Q2 2025), $158505.0 (Q1 2025), and $158505.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2023 | 48,961.00 |
| Jul 31, 2023 | 49,905.00 |
| Apr 30, 2023 | 48,769.00 |
| Jan 31, 2023 | 49,790.00 |
| Oct 31, 2022 | 50,544.00 |
| Jul 31, 2022 | 43,260.00 |
| Apr 30, 2022 | 44,014.00 |
| Jan 31, 2022 | 44,906.00 |
| Oct 31, 2021 | 276.00 |
| Jul 31, 2021 | 414.00 |
| Apr 30, 2021 | 552.00 |
| Jan 31, 2021 | 689.00 |
| Oct 31, 2020 | 3,327.00 |
| Jul 31, 2020 | 5,965.00 |